Different indications, warnings and precautions, and contraindications for the same drug-an international comparison of prescribing information for commonly used psychiatric drugs-Reference-Cited by-同舟云学术

Different indications, warnings and precautions, and contraindications for the same drug-an international comparison of prescribing information for commonly used psychiatric drugs

Published:2012-12-26 Issue:3 Volume:22 Page:329-333
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Pfistermeister Barbara¹,Schenk Christian¹,Kornhuber Johannes²,Bürkle Thomas³,Fromm Martin F¹,Maas Renke¹

Affiliation:

1. Institute of Experimental and Clinical Pharmacology and Toxicology; Friedrich-Alexander-Universität Erlangen-Nürnberg; Erlangen Germany

2. Department of Psychiatry and Psychotherapy; University Hospital, Friedrich-Alexander-Universität Erlangen-Nürnberg; Erlangen Germany

3. Chair of Medical Informatics; Friedrich-Alexander-Universität Erlangen-Nürnberg; Erlangen Germany

Funder

German Federal Ministry of Education and Research

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.3389/fullpdf

Reference12 articles.

1. International consensus statement on major depressive disorder;Nutt;J Clin Psychiatry,2010

2. Treatment adequacy for anxiety and depressive disorders in six European countries;Fernandez;Br J Psychiatry,2007

3. Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature;Bergk;Eur J Clin Pharmacol,2005

4. Prescribing information in 26 countries: a comparative study;Reggi;Eur J Clin Pharmacol,2003

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective analysis of adverse drug reaction enquiries to a hospital drug information service: lessons to be learned to increase in-hospital drug safety;International Journal of Pharmacy Practice;2024-07-18

2. An analysis of international strategies for monitoring and preventability described in medicinal product information: a study protocol;2024-06-15

3. Evaluation of marketing authorization and labels of medicines in 2021 WHO Model List of Essential Medicines for Children in China, the Russian Federation and Brazil;Health Research Policy and Systems;2024-03-05

4. Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems;Frontiers in Drug Safety and Regulation;2024-01-26

5. Comparison of New Drug Indications Approved in the United States, Europe, and Japan from 2001 to 2020;Biological and Pharmaceutical Bulletin;2022-10-01